Related Experiment Video
Updated: May 16, 2025

06:13
Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain
Published on: March 1, 2024
795
Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies
1Usona Institute, Fitchburg, Wisconsin 53711-5300, United States.
ACS Medicinal Chemistry Letters
|May 14, 2025
Abstract:
Psilocybin demonstrates a clinically meaningful reduction in phantom and residual limb pain. Adaptive sensory environments (ASEs) separately offer biosensor-guided modulation of psychological states during psychoactive therapy. This Patent Highlight explores the pharmacological findings of a psilocybin trial and discusses future integration with ASE systems to precision and scale psychedelic-assisted interventions.

